Sage Therapeutics Stock: Analysts Upgrade to Hold, Impact on Investors
The financial world is buzzing with the latest assessment of Sage Therapeutics (NASDAQ:SAGE), as leading research firm Wall Street Zen recently upgraded the biopharmaceutical company’s stock to…